Lab Reagents
Hitachi Exocomplete Laboratories manufactures the hitachi chemical diagnostics mountain view ca reagents distributed by Genprice. The Hitachi Chemical Diagnostics Mountain View Ca reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Hitachi Exocomplete. Other Hitachi products are available in stock. Specificity: Hitachi Category: Chemical Group: Diagnostics Mountain
Diagnostics Mountain information
Chemical Defined Xeno-free Cell Cryopreservation Medium |
|
abx298009-20ml |
Abbexa |
20 ml |
EUR 244 |
- Shipped within 5-10 working days.
|
Mouse iPSC Chemical Reprogramming Cocktails Kit plus |
|
K1021-100 |
ApexBio |
Chemical Reprogramming Cocktail 1/2+Dual Inhibition (2i) Medium Additive for 100 mL medium |
EUR 470 |
Mouse iPSC Chemical Reprogramming Cocktails Kit plus |
|
K1021-500 |
ApexBio |
Chemical Reprogramming Cocktail 1/2+Dual Inhibition (2i) Medium Additive for 500 mL medium |
EUR 644 |
AN3 CA |
|
C0026002 |
Addexbio |
One Frozen vial |
EUR 543 |
CA 074 |
|
A1926-1 |
ApexBio |
1 mg |
EUR 148 |
|
Description: CA-074, a specific cathepsin B inhibitor, also abolished the neurotoxic effects caused by Abeta42-activated BV2 cell [1]. Co-treatment of cultures with the cathepsin B inhibitors CA-074 or Z-FA-FMK suppressed the cytostatic effects of TPA and activation of pro-uPA [2]. |
CA 074 |
|
A1926-10 |
ApexBio |
10 mg |
EUR 485 |
|
Description: CA-074, a specific cathepsin B inhibitor, also abolished the neurotoxic effects caused by Abeta42-activated BV2 cell [1]. Co-treatment of cultures with the cathepsin B inhibitors CA-074 or Z-FA-FMK suppressed the cytostatic effects of TPA and activation of pro-uPA [2]. |
CA 074 |
|
A1926-25 |
ApexBio |
25 mg |
EUR 746 |
|
Description: CA-074, a specific cathepsin B inhibitor, also abolished the neurotoxic effects caused by Abeta42-activated BV2 cell [1]. Co-treatment of cultures with the cathepsin B inhibitors CA-074 or Z-FA-FMK suppressed the cytostatic effects of TPA and activation of pro-uPA [2]. |
CA 074 |
|
A1926-5 |
ApexBio |
5 mg |
EUR 311 |
|
Description: CA-074, a specific cathepsin B inhibitor, also abolished the neurotoxic effects caused by Abeta42-activated BV2 cell [1]. Co-treatment of cultures with the cathepsin B inhibitors CA-074 or Z-FA-FMK suppressed the cytostatic effects of TPA and activation of pro-uPA [2]. |
CA 074 |
|
A1926-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 432 |
|
Description: CA-074, a specific cathepsin B inhibitor, also abolished the neurotoxic effects caused by Abeta42-activated BV2 cell [1]. Co-treatment of cultures with the cathepsin B inhibitors CA-074 or Z-FA-FMK suppressed the cytostatic effects of TPA and activation of pro-uPA [2]. |
CA 074 |
|
A1926-S |
ApexBio |
Evaluation Sample |
EUR 81 |
|
Description: CA-074, a specific cathepsin B inhibitor, also abolished the neurotoxic effects caused by Abeta42-activated BV2 cell [1]. Co-treatment of cultures with the cathepsin B inhibitors CA-074 or Z-FA-FMK suppressed the cytostatic effects of TPA and activation of pro-uPA [2]. |
Gastrointestinal Cancer Antigen (CA 19-9), antigen grade |
|
CA1991-N-10 |
Alpha Diagnostics |
10 KU |
EUR 529 |
